MIGS, pronounced /mɪɡz/, is an acronym for "Minimally Invasive Glaucoma Surgery". It refers to a group of surgical procedures designed to lower intraocular pressure in patients with glaucoma. The word is spelled with a single "G" because the sound is a voiced velar plosive, commonly represented by the letter "G". The "S" at the end of the word indicates a plural form, as it refers to multiple surgical techniques falling under the category of Minimally Invasive Glaucoma Surgery.
MIGS is an acronym for Minimally Invasive Glaucoma Surgery. It refers to a range of surgical procedures that are designed to reduce intraocular pressure (IOP) and manage glaucoma, a progressive eye disease that can lead to vision loss and blindness.
MIGS techniques involve micro-incisions and the utilization of specialized devices to enhance fluid drainage and improve the outflow of aqueous humor in the eye. These procedures are typically less invasive and have lower risk profiles compared to traditional glaucoma surgeries.
One common MIGS procedure is trabecular micro-bypass surgery, wherein a tiny device called a stent is placed into the trabecular meshwork to facilitate the flow of aqueous humor and reduce IOP. Another example is canaloplasty, which involves the use of a microcatheter to expand and reopen the eye's natural drainage canal, known as Schlemm's canal.
MIGS techniques aim to be safer, faster, and have faster recovery times compared to conventional glaucoma surgeries, such as trabeculectomy or tube shunt procedures. These innovations have revolutionized the management of glaucoma by providing an intermediate option between medications and more invasive surgical procedures, giving ophthalmologists and patients more treatment options tailored to individual needs.
Despite their benefits, it is important to note that MIGS procedures may not be suitable for all glaucoma patients, and the decision to undergo a specific surgical technique should be made in consultation with an eye care professional.